Valdez-Acosta, S., Zubiaur Precioso, P., Casado, M. Á., Novalbos, J., Casajús, A., Campodónico, D., . . . Abad Santos, F. (2023). Preemptive TPMT genotyping and adherence to genotype-based therapeutic recommendations reduces the healthcare cost in patients receiving azathioprine or 6-mercaptopurine for autoimmune diseases.
Citación estilo ChicagoValdez-Acosta, Sarahí, Pablo Zubiaur Precioso, Miguel Ángel Casado, Jesús Novalbos, Ana Casajús, Diana Campodónico, Itziar Oyagüez, y Francisco Abad Santos. Preemptive TPMT Genotyping and Adherence to Genotype-based Therapeutic Recommendations Reduces the Healthcare Cost in Patients Receiving Azathioprine or 6-mercaptopurine for Autoimmune Diseases. 2023.
Cita MLAValdez-Acosta, Sarahí, et al. Preemptive TPMT Genotyping and Adherence to Genotype-based Therapeutic Recommendations Reduces the Healthcare Cost in Patients Receiving Azathioprine or 6-mercaptopurine for Autoimmune Diseases. 2023.